View original post here:
GSK and Vir Submit Emergency Use Authorization Application to FDA for Intramuscular Administration of Sotrovimab for the Early Treatment of COVID-19

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh